Target intelligence / Profile preview

Chondron

Molecular classification
Other
01

Overview

A chondron is the primary functional, metabolic, and mechanical unit of articular cartilage, consisting of a chondrocyte and its immediate pericellular matrix (PCM) (Poole, C. A., 1997, PubMed). The PCM is a specialized region characterized by a high concentration of type VI collagen, aggrecan, and hyaluronan, which serves as a critical interface for mechanotransduction between the extracellular matrix and the chondrocyte (Youn, I., et al., 2006, PubMed). This microenvironment protects the cell from high mechanical loads and modulates the biochemical signaling necessary for maintaining cartilage integrity. In diseases such as osteoarthritis, the chondron undergoes significant structural and compositional changes, leading to impaired cellular responses and tissue breakdown. While not a traditional molecular drug target, the chondron is highly relevant in regenerative medicine; therapies utilizing intact chondrons have shown superior metabolic activity and matrix production compared to isolated chondrocytes in tissue engineering applications (Graff, R. D., et al., 2003, PubMed). Preservation of the chondron structure is considered a key goal in chondroprotective strategies to maintain joint health.

Other names
Chondrocyte-pericellular matrix unitFunctional unit of articular cartilage
02

Mechanism of action

Not applicable; the chondron is a histological and functional unit rather than a single molecular target.

03

Biological functions

MechanotransductionCartilage homeostasisExtracellular matrix synthesisSignal transduction
04

Disease associations

OsteoarthritisCartilage degenerationChondrodysplasia
05

Safety considerations

Structural degradation in disease statesTechnical challenges in therapeutic isolation and transplantation
06

Biomarkers

Type VI collagenAggrecanHyaluronan

Beyond the preview

Go deeper on Chondron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chondron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call